Australia's largest stock trading and investment forum Australia's #1 stock forum

When Lockdown Ends in Melbourne I'm Outta Here!, page-280

First 280 Last

Share
Profile

Follow
skiptdouglas

8,560 Posts.

2

28/09/21

06:42

Post #: 56390127
Share

Originally posted by Poppy63: ↑

I find it hilarious how the only form of defence for some clowns is to drop down to schoolyard taunts whilst trying to portray some form of superiority.
Anyway lets get back on topic......

Talking to medicos it seems rushing in for Pfizer may not be as good as initially thought. Does Moderna have it over Pfizer ????? Papers are starting to roll out giving up to 5% more effectiveness for Moderna. Also Research published by the Centers for Disease Control and Prevention found that the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91% to 77% after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period. So better start lining up for those boosters already prior to the increased chat of opening up borders.

Seems that medico I discussed this with a 3 months ago may have been on the right track in advising to hang off for a while.

Expand

https://www.cdc.gov/mmwr/volumes/70/wr/mm7038e1.htm?s_cid=mm7038e1_w

Yeah interesting , had a read this morning .

Nevertheless, the vaccinated patients tended to be older people — the Pfizer cohort had a median age of 68 — and it was unclear whether vaccine effectiveness had changed much in younger age groups. Previous studies have shown lower levels of protection in older people.
Upvote

Reply

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

First 280 Last

SPONSORED BY